Gene · 2213
NIH grants2,625
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,161 to 1,180 of 2,625
Download this page as JSON| Grant | Title | FCGR2B papers | Newest fiscal year |
|---|---|---|---|
| R21AI130712 | Viral Immune Evasion of FcRn Functions | 1 | 2019 |
| R21AI135999 | Mechanism to evade host immunity by Mucorales fungi | 1 | 2019 |
| R21AI136527 | Generation and Characterization of Mice with Tissue Specific Expression of Lupus Risk ITGAM SNPs | 1 | 2019 |
| R21AI136556 | Antibody and viral determinants of protection against CMV infection following gB/MF59 vaccination | 1 | 2019 |
| R21CA209298 | A novel genetic pathway for survival of B-lymphoblastic leukemia-initiating cells | 1 | 2019 |
| R21ES028957 | Endocrine Disruptors, Ahr Signaling, and Placentation | 1 | 2019 |
| R21NS107894 | Immune-mediated therapies in a genetically engineered murine model of diffuse intrinsic pontine glioma | 1 | 2019 |
| R21NS110520 | The role of transcriptional cofactor GRIP1 in microglia-driven neuroinflammation | 1 | 2019 |
| R25DA027995 | RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICS | 1 | 2019 |
| R25GM109421 | Integrated scientific and professional PhD training program in biomedical science | 1 | 2019 |
| R37AI020241 | Human Eosinophils: Mechanisms of Functioning | 1 | 2019 |
| R44DK117472 | MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases | 1 | 2019 |
| R56AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer’s disease | 1 | 2019 |
| R56AR065538 | Ly6 family members in neutrophil biology | 1 | 2019 |
| R56DK121511 | Lymphatics in the liver | 1 | 2019 |
| R56MH115853 | CNS Viral Escape in HIV-infected Adults | 1 | 2019 |
| R61AI136007 | Gonorrhea and HIV prevention with intravaginal ring drug delivery | 1 | 2019 |
| SC2GM111149 | Glial uptake of dopamine after L-DOPA medication (hurricane recovery) | 1 | 2019 |
| T32GM007309 | Medical Scientist Training Program | 1 | 2019 |
| T32GM008715 | Biotechnology Training Grant | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/grants?page=59